Dr Rammohan Gumpeni, MD - Medicare Pulmonary Disease in Flushing, NY

Dr Rammohan Gumpeni, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Flushing, New York. He graduated from medical school in 1968 and has 56 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice New York Queens Medicine And Surgery, P.c. and his current practice location is 5645 Main St, #wa 100, Flushing, New York. You can reach out to his office (for appointments etc.) via phone at (718) 670-1405.

Dr Rammohan Gumpeni is licensed to practice in New York (license number 111523-1) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1710069158.

Contact Information

Dr Rammohan Gumpeni, MD
5645 Main St, #wa 100,
Flushing, NY 11355-5045
(718) 670-1405
(718) 461-2943



Physician's Profile

Full NameDr Rammohan Gumpeni
GenderMale
SpecialityPulmonary Disease
Experience56 Years
Location5645 Main St, Flushing, New York
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Rammohan Gumpeni graduated from medical school in 1968
  NPI Data:
  • NPI Number: 1710069158
  • Provider Enumeration Date: 10/19/2006
  • Last Update Date: 06/13/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 8527123389
  • Enrollment ID: I20090211000765

Medical Identifiers

Medical identifiers for Dr Rammohan Gumpeni such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1710069158NPI-NPPES
061205476GU01OtherFAMILY HEALTH PLUS
124016OtherAETNA HMO
5C6148OtherHEALTHNET
11-3347168OtherMULTIPLAN
000000106306OtherGHI HMO
0C048POtherHIP
10209256OtherAMERIGROUP
4231839OtherAETNA PPO / POS
431637NOtherCIGNA
DS486OtherOXFORD
000084001OtherAMERICHOICE
000197150101OtherHEALTHPLUS
11P6421OtherNYPRESBYTERIAN CHP
160039OtherELDERPLAN
00200793MedicaidNY
0074822OtherGHI PPO
100027142401OtherUNITED HEALTHCARE
693961OtherEMPIRE BC/BS

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RP1001XInternal Medicine - Pulmonary Disease 111523 (New York)Secondary
207RP1001XInternal Medicine - Pulmonary Disease 111523-1 (New York)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
New York-presbyterian/queensFlushing, NYHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
New York Queens Medicine And Surgery, P.c.4082883673371

News Archive

Scientists synthesize multifunctional polymer that can decontaminate biological and chemical toxins

In an ongoing effort to mirror the ability of biological tissues to respond rapidly and appropriately to changing environments, scientists from the McGowan Institute for Regenerative Medicine have synthesized a single, multifunctional polymer material that can decontaminate both biological and chemical toxins. They described the findings recently in Biomaterials.

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing agreement that grants XenaCare Holdings (OTCBB:XCHO) ongoing exclusive United States marketing and distribution rights for Cobroxin in return for meeting specific minimum performance requirements.

XOMA 052 reduces adverse consequences that lead to development of congestive heart failure

XOMA Ltd., a leader in the discovery and development of antibody therapeutics, announced results demonstrating that a murine equivalent of XOMA 052, its novel, high-affinity antibody to interleukin-1 beta (IL-1 beta), significantly reduced adverse consequences that usually lead to the development of congestive heart failure in a mouse model of acute myocardial infarction (heart attack).

U-M's epilepsy surgery could successfully treat patients with seizures

John Ligerakis was told he had to learn to live with seizures that had made it challenging for him to work or drive a car. A young professional just starting his career, Ligerakis was devastated about what his future might bring.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Rammohan Gumpeni allows following entities to bill medicare on his behalf.
Entity NameNewyork-presbyterian-queens
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013960962
PECOS PAC ID: 7315839933
Enrollment ID: O20040329000273

News Archive

Scientists synthesize multifunctional polymer that can decontaminate biological and chemical toxins

In an ongoing effort to mirror the ability of biological tissues to respond rapidly and appropriately to changing environments, scientists from the McGowan Institute for Regenerative Medicine have synthesized a single, multifunctional polymer material that can decontaminate both biological and chemical toxins. They described the findings recently in Biomaterials.

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing agreement that grants XenaCare Holdings (OTCBB:XCHO) ongoing exclusive United States marketing and distribution rights for Cobroxin in return for meeting specific minimum performance requirements.

XOMA 052 reduces adverse consequences that lead to development of congestive heart failure

XOMA Ltd., a leader in the discovery and development of antibody therapeutics, announced results demonstrating that a murine equivalent of XOMA 052, its novel, high-affinity antibody to interleukin-1 beta (IL-1 beta), significantly reduced adverse consequences that usually lead to the development of congestive heart failure in a mouse model of acute myocardial infarction (heart attack).

U-M's epilepsy surgery could successfully treat patients with seizures

John Ligerakis was told he had to learn to live with seizures that had made it challenging for him to work or drive a car. A young professional just starting his career, Ligerakis was devastated about what his future might bring.

Read more Medical News

› Verified 8 days ago

Entity NameNew York Queens Medicine And Surgery, P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1003114851
PECOS PAC ID: 4082883673
Enrollment ID: O20110817000163

News Archive

Scientists synthesize multifunctional polymer that can decontaminate biological and chemical toxins

In an ongoing effort to mirror the ability of biological tissues to respond rapidly and appropriately to changing environments, scientists from the McGowan Institute for Regenerative Medicine have synthesized a single, multifunctional polymer material that can decontaminate both biological and chemical toxins. They described the findings recently in Biomaterials.

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing agreement that grants XenaCare Holdings (OTCBB:XCHO) ongoing exclusive United States marketing and distribution rights for Cobroxin in return for meeting specific minimum performance requirements.

XOMA 052 reduces adverse consequences that lead to development of congestive heart failure

XOMA Ltd., a leader in the discovery and development of antibody therapeutics, announced results demonstrating that a murine equivalent of XOMA 052, its novel, high-affinity antibody to interleukin-1 beta (IL-1 beta), significantly reduced adverse consequences that usually lead to the development of congestive heart failure in a mouse model of acute myocardial infarction (heart attack).

U-M's epilepsy surgery could successfully treat patients with seizures

John Ligerakis was told he had to learn to live with seizures that had made it challenging for him to work or drive a car. A young professional just starting his career, Ligerakis was devastated about what his future might bring.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Rammohan Gumpeni is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Rammohan Gumpeni, MD
7568 187th St,
Fresh Meadows, NY 11366-1726

Ph: (718) 670-1405
Dr Rammohan Gumpeni, MD
5645 Main St, #wa 100,
Flushing, NY 11355-5045

Ph: (718) 670-1405

News Archive

Scientists synthesize multifunctional polymer that can decontaminate biological and chemical toxins

In an ongoing effort to mirror the ability of biological tissues to respond rapidly and appropriately to changing environments, scientists from the McGowan Institute for Regenerative Medicine have synthesized a single, multifunctional polymer material that can decontaminate both biological and chemical toxins. They described the findings recently in Biomaterials.

XenaCare Holdings to market Cobroxin pain reliever drug in U.S.

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing agreement that grants XenaCare Holdings (OTCBB:XCHO) ongoing exclusive United States marketing and distribution rights for Cobroxin in return for meeting specific minimum performance requirements.

XOMA 052 reduces adverse consequences that lead to development of congestive heart failure

XOMA Ltd., a leader in the discovery and development of antibody therapeutics, announced results demonstrating that a murine equivalent of XOMA 052, its novel, high-affinity antibody to interleukin-1 beta (IL-1 beta), significantly reduced adverse consequences that usually lead to the development of congestive heart failure in a mouse model of acute myocardial infarction (heart attack).

U-M's epilepsy surgery could successfully treat patients with seizures

John Ligerakis was told he had to learn to live with seizures that had made it challenging for him to work or drive a car. A young professional just starting his career, Ligerakis was devastated about what his future might bring.

Read more News

› Verified 8 days ago


Internal Medicine Doctors in Flushing, NY

Ms. Min Cai, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 4105 College Point Blvd, Suite 1c, Flushing, NY 11355
Phone: 718-321-0558    Fax: 718-321-1672
Dr. David Scott Rubin, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 13847 Horace Harding Expy, Flushing, NY 11367
Phone: 718-461-5813    Fax: 718-321-8095
Xueshu Zhang, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 133-47 Sanford Avenue, Suite 1f, Flushing, NY 11355
Phone: 718-359-5780    Fax: 718-359-5821
Haoxu Ouyang,
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 13227 41st Rd # 2c, Flushing, NY 11355
Phone: 718-269-5055    
Mu-i Karen Kuo, M.D.
Pulmonary Disease
Medicare: Medicare Enrolled
Practice Location: 13259 41st Rd, Suite Cb, Flushing, NY 11355
Phone: 718-939-6234    Fax: 718-939-6235
Evan Choi, M.D.
Pulmonary Disease
Medicare: Medicare Enrolled
Practice Location: 5645 Main St, Flushing, NY 11355
Phone: 718-670-2000    
Dr. Mustafa Salehmohamed, D.O.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 5645 Main St, Wa-100, Flushing, NY 11355
Phone: 718-670-1405    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.